speb/financial-data huggingface dataset:
TRMD income_statement (quarterly, 2026-03-31) — Operating Revenue: 402000000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 102123339.00
TRMD balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 53200000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 230900000.00
TRMD income_statement (quarterly, 2026-03-31) — Other Gand A: 23000000.00
TRMD income_statement (quarterly, 2026-03-31) — Other Income Expense: 4000000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 3900000.00
TRMD cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 24900000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 810000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 7900000.00
TRMD income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 67500000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Other Properties: 2100000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Other Receivables: 32700000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Payables: 67900000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 67900000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 14300000.00
TRMD income_statement (quarterly, 2026-03-31) — Pretax Income: 124000000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Properties: 9000000.00
TRMD cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -1100000.00
TRMD cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -183200000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Receivables: 282300000.00
TRMD income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 174200000.00
TRMD income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 59700000.00
TRMD cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -96900000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1915100000.00
TRMD cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 29300000.00
TRMD income_statement (quarterly, 2026-03-31) — Selling General And Administration: 23000000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Share Issued: 102123339.00
TRMD income_statement (quarterly, 2026-03-31) — Special Income Charges: 4000000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2273000000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2267300000.00
TRMD income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 51612.90
TRMD income_statement (quarterly, 2026-03-31) — Tax Provision: 1600000.00
TRMD income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.01
TRMD cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -1700000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Total Assets: 3532300000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 3068100000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Total Debt: 1081800000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2273000000.00
TRMD income_statement (quarterly, 2026-03-31) — Total Expenses: 264700000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1259300000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2956800000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 848400000.00
TRMD income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 141300000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 700000.00
TRMD income_statement (quarterly, 2026-03-31) — Total Unusual Items: 4000000.00
TRMD income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 4000000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 45200000.00
TRMD balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 0.00
TRMD balance_sheet (quarterly, 2026-03-31) — Working Capital: 164600000.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -46040000.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 4027000.00
TRMED.OL cash_flow (annual, 2021-12-31) — Capital Expenditure: -259000.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Cash Equivalents: 276709000.00
TRMED.OL income_statement (annual, 2021-12-31) — General And Administrative Expense: 24890000.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Investmentsin Subsidiariesat Cost: 0.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 0.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 0.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 48008000.00
TRMED.OL cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: -1229000.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 4461000.00
TRMED.OL cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4568000.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Prepaid Assets: 3758000.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Properties: 0.00
TRMED.OL income_statement (annual, 2021-12-31) — Research And Development: 317981000.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Restricted Cash: 997000.00
TRMED.OL income_statement (annual, 2021-12-31) — Selling General And Administration: 24890000.00
TRMED.OL balance_sheet (annual, 2021-12-31) — Taxes Receivable: 4182000.00
TRMED.OL cash_flow (annual, 2021-12-31) — Taxes Refund Paid: -844000.00
TRMED.OL income_statement (annual, 2021-12-31) — Total Other Finance Cost: 144000.00
TRMED.OL income_statement (annual, 2022-12-31) — +Operating Expense: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Accounts Payable: 9093000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -10475000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 66550000.00
TRMED.OL income_statement (annual, 2022-12-31) — Basic Average Shares: 118166494.00
TRMED.OL income_statement (annual, 2022-12-31) — Basic EPS: -2.63
TRMED.OL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 277706000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 4027000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Capital Expenditure: -5628000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 159000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Capital Stock: 23207000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 96552000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 96552000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Cash Equivalents: 96552000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Cash Financial: 96552000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Change In Working Capital: -97979000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Changes In Cash: -183418000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Common Stock: 23207000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 63842000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Common Stock Issuance: 250808000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Current Assets: 109108000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 159000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 159000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Current Liabilities: 44283000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Depreciation: 11202000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 11202000.00
TRMED.OL income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Depreciation Income Statement: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Diluted Average Shares: 118166494.00
TRMED.OL income_statement (annual, 2022-12-31) — Diluted EPS: -2.63
TRMED.OL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -311241000.00
TRMED.OL income_statement (annual, 2022-12-31) — EBIT: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — EBITDA: 11202000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 4428000.00
TRMED.OL cash_flow (annual, 2022-12-31) — End Cash Position: 98716000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Financing Cash Flow: 228125000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Free Cash Flow: -414707000.00
TRMED.OL income_statement (annual, 2022-12-31) — General And Administrative Expense: 28773000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Goodwill: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Gross PPE: 11013000.00
TRMED.OL income_statement (annual, 2022-12-31) — Interest Expense: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Interest Income: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Interest Income Non Operating: 0.00
TRMED.OL cash_flow (annual, 2022-12-31) — Interest Paid Cff: -66000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Interest Received Cfi: 3164000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Invested Capital: 63842000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2464000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Investmentsin Subsidiariesat Cost: 0.00
TRMED.OL cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 250808000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 6880000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
TRMED.OL cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 250808000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -4428000.00
TRMED.OL income_statement (annual, 2022-12-31) — Net Income: -311241000.00
TRMED.OL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -311241000.00
TRMED.OL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: -311241000.00
TRMED.OL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -311241000.00
TRMED.OL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 0.00
TRMED.OL cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -310372000.00
TRMED.OL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -311241000.00
TRMED.OL income_statement (annual, 2022-12-31) — Net Interest Income: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Net PPE: 538000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -5628000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 63842000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1520000.00
TRMED.OL income_statement (annual, 2022-12-31) — Normalized EBITDA: 11202000.00
TRMED.OL income_statement (annual, 2022-12-31) — Normalized Income: 0.00
TRMED.OL cash_flow (annual, 2022-12-31) — Operating Cash Flow: -409079000.00
TRMED.OL income_statement (annual, 2022-12-31) — Operating Income: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 119095698.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 28505000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Other Non Cash Items: -3098000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Other Non Current Assets: -1000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Other Properties: 4133000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Other Receivables: 5021000.00
TRMED.OL income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Payables: 9852000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1434000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2465000.00
TRMED.OL income_statement (annual, 2022-12-31) — Pretax Income: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Properties: 0.00
TRMED.OL cash_flow (annual, 2022-12-31) — Purchase Of PPE: -5628000.00
TRMED.OL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 11202000.00
TRMED.OL income_statement (annual, 2022-12-31) — Research And Development: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Restricted Cash: 2164000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Retained Earnings: -25915000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Selling General And Administration: 28773000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Share Issued: 119095698.00
TRMED.OL cash_flow (annual, 2022-12-31) — Stock Based Compensation: -3302000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 63842000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Tangible Book Value: 63842000.00
TRMED.OL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Tax Provision: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Taxes Receivable: 2906000.00
TRMED.OL cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -1102000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Total Assets: 109645000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Total Capitalization: 63842000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Total Debt: 159000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 63842000.00
TRMED.OL income_statement (annual, 2022-12-31) — Total Expenses: 0.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 45803000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 537000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1520000.00
TRMED.OL income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 0.00
TRMED.OL income_statement (annual, 2022-12-31) — Total Other Finance Cost: 93000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Total Tax Payable: 759000.00
TRMED.OL balance_sheet (annual, 2022-12-31) — Working Capital: 64825000.00
TRMED.OL income_statement (annual, 2023-12-31) — +Operating Expense: 7163000.00
TRMED.OL income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Accounts Payable: 2103000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -3926000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 246069000.00
TRMED.OL income_statement (annual, 2023-12-31) — Basic Average Shares: 175216184.00
TRMED.OL income_statement (annual, 2023-12-31) — Basic EPS: -0.15
TRMED.OL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 98716000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Capital Stock: 46708000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 41284000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 41284000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Cash Financial: 41284000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -32403000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Change In Working Capital: -32403000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Changes In Cash: -58146000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Common Stock: 46708000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Common Stock Equity: 271925000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Common Stock Issuance: 147000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Current Assets: 45346000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Current Liabilities: 4446000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Depreciation: 717000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 717000.00
TRMED.OL income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 331000.00
TRMED.OL income_statement (annual, 2023-12-31) — Depreciation Income Statement: 331000.00
TRMED.OL income_statement (annual, 2023-12-31) — Diluted Average Shares: 175216184.00
TRMED.OL income_statement (annual, 2023-12-31) — Diluted EPS: -0.15
TRMED.OL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -26561000.00
TRMED.OL income_statement (annual, 2023-12-31) — EBIT: -5560000.00
TRMED.OL income_statement (annual, 2023-12-31) — EBITDA: -4843000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 1196000.00
TRMED.OL cash_flow (annual, 2023-12-31) — End Cash Position: 41767000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Financing Cash Flow: -332000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Free Cash Flow: -64090000.00
TRMED.OL income_statement (annual, 2023-12-31) — General And Administrative Expense: 1571000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Goodwill: 37216000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 284481000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Gross PPE: 4933000.00
TRMED.OL income_statement (annual, 2023-12-31) — Interest Expense: 0.00
TRMED.OL income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 0.00
TRMED.OL income_statement (annual, 2023-12-31) — Interest Income: 2019000.00
TRMED.OL income_statement (annual, 2023-12-31) — Interest Income Non Operating: 2019000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Interest Paid Cff: 0.00
TRMED.OL cash_flow (annual, 2023-12-31) — Interest Received Cfi: 2019000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Invested Capital: 271925000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Investing Cash Flow: 6276000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 147000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 174000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 4257000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 147000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -1196000.00
TRMED.OL income_statement (annual, 2023-12-31) — Net Income: -26561000.00
TRMED.OL income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -26561000.00
TRMED.OL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -5560000.00
TRMED.OL income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -21000000.00
TRMED.OL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -26561000.00
TRMED.OL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -5561000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -26561000.00
TRMED.OL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -26560000.00
TRMED.OL income_statement (annual, 2023-12-31) — Net Interest Income: 1850000.00
TRMED.OL income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1850000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Net PPE: 1007000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -12556000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 54464000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
TRMED.OL income_statement (annual, 2023-12-31) — Normalized EBITDA: -4843000.00
TRMED.OL income_statement (annual, 2023-12-31) — Normalized Income: -5561000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Operating Cash Flow: -64090000.00
TRMED.OL income_statement (annual, 2023-12-31) — Operating Income: -7163000.00
TRMED.OL income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 239698534.00
TRMED.OL cash_flow (annual, 2023-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1130000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 247265000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Other Non Cash Items: -5988000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1000.00
TRMED.OL income_statement (annual, 2023-12-31) — Other Operating Expenses: 1013000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Other Properties: 4759000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Other Receivables: 2596000.00
TRMED.OL income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Payables: 2103000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 479000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Prepaid Assets: 496000.00
TRMED.OL income_statement (annual, 2023-12-31) — Pretax Income: -5560000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Properties: 0.00
TRMED.OL cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
TRMED.OL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 717000.00
TRMED.OL income_statement (annual, 2023-12-31) — Research And Development: 945000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Restricted Cash: 482000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Retained Earnings: -20852000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Sale Of Business: 4257000.00
TRMED.OL income_statement (annual, 2023-12-31) — Selling General And Administration: 1571000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Share Issued: 239698534.00
TRMED.OL cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2100000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Stockholders Equity: 271925000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Tangible Book Value: -12556000.00
TRMED.OL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
TRMED.OL income_statement (annual, 2023-12-31) — Tax Provision: 0.00
TRMED.OL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Taxes Receivable: 488000.00
TRMED.OL cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -759000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Total Assets: 330835000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Total Capitalization: 271925000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Total Debt: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 271925000.00
TRMED.OL income_statement (annual, 2023-12-31) — Total Expenses: 7163000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 58910000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 285489000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 54464000.00
TRMED.OL income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -7160000.00
TRMED.OL income_statement (annual, 2023-12-31) — Total Other Finance Cost: 169000.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Total Tax Payable: 0.00
TRMED.OL balance_sheet (annual, 2023-12-31) — Working Capital: 40900000.00
TRMED.OL income_statement (annual, 2024-12-31) — +Operating Expense: 43900000.00
TRMED.OL income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Accounts Payable: 15230000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 15230000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -4320000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -4320000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 344106000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 344106000.00
TRMED.OL income_statement (annual, 2024-12-31) — Basic Average Shares: 235800000.00
TRMED.OL income_statement (annual, 2024-12-31) — Basic EPS: -0.18
TRMED.OL cash_flow (annual, 2024-12-31) — Beginning Cash Position: 41800000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Capital Expenditure: -100000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 737000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 737000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Capital Stock: 56098000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Capital Stock: 56098000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 122819000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 122819000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 122819000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 122819000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Cash Financial: 122819000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Cash Financial: 122819000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Change In Inventory: 0.00
TRMED.OL cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1900000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Change In Payable: 13100000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Change In Receivables: 0.00
TRMED.OL cash_flow (annual, 2024-12-31) — Change In Working Capital: 15000000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Changes In Cash: 81600000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Common Stock: 56098000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Common Stock: 56098000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Common Stock Equity: 337144000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 337144000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Common Stock Issuance: 114300000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Current Assets: 129911000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Current Assets: 129911000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 437000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 437000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 437000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 437000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Current Liabilities: 22900000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 22900000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Depreciation: 2400000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2400000.00
TRMED.OL income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 2400000.00
TRMED.OL income_statement (annual, 2024-12-31) — Depreciation Income Statement: 2400000.00
TRMED.OL income_statement (annual, 2024-12-31) — Diluted Average Shares: 235800000.00
TRMED.OL income_statement (annual, 2024-12-31) — Diluted EPS: -0.18
TRMED.OL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -42200000.00
TRMED.OL income_statement (annual, 2024-12-31) — EBIT: -42500000.00
TRMED.OL income_statement (annual, 2024-12-31) — EBITDA: -40100000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
TRMED.OL cash_flow (annual, 2024-12-31) — End Cash Position: 123400000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Financing Cash Flow: 104000000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Free Cash Flow: -23800000.00
TRMED.OL income_statement (annual, 2024-12-31) — General And Administrative Expense: 29071000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Goodwill: 37216000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Goodwill: 37216000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 283039000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 283039000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Gross PPE: 5746000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Gross PPE: 5746000.00
TRMED.OL income_statement (annual, 2024-12-31) — Interest Expense: 100000.00
TRMED.OL income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 100000.00
TRMED.OL income_statement (annual, 2024-12-31) — Interest Income: 1500000.00
TRMED.OL income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1500000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Interest Paid Cff: -100000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Interest Received Cfi: 1500000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Invested Capital: 337144000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Invested Capital: 337144000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Investing Cash Flow: 1300000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 114300000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 300000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 300000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 300000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 300000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 174000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 174000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
TRMED.OL cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 114300000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
TRMED.OL income_statement (annual, 2024-12-31) — Net Income: -42200000.00
TRMED.OL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -42200000.00
TRMED.OL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -42200000.00
TRMED.OL income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 0.00
TRMED.OL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -42200000.00
TRMED.OL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -42200000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -42600000.00
TRMED.OL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -42200000.00
TRMED.OL income_statement (annual, 2024-12-31) — Net Interest Income: 1400000.00
TRMED.OL income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1400000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 1000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -100000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Net PPE: 1426000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Net PPE: 1426000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -100000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 54105000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 54105000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 54034000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 54034000.00
TRMED.OL income_statement (annual, 2024-12-31) — Normalized EBITDA: -40100000.00
TRMED.OL income_statement (annual, 2024-12-31) — Normalized Income: -42200000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Operating Cash Flow: -23700000.00
TRMED.OL income_statement (annual, 2024-12-31) — Operating Income: -43900000.00
TRMED.OL income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 281180892.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 281180892.00
TRMED.OL cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Other Current Assets: 1000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 1000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Other Current Liabilities: -1000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: -1000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 245823000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 245823000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1400000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 2000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 100000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 100000.00
TRMED.OL income_statement (annual, 2024-12-31) — Other Operating Expenses: 25000000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Other Properties: 5572000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Other Properties: 5572000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Other Receivables: 4189000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Other Receivables: 4189000.00
TRMED.OL income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Payables: 16344000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Payables: 16344000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1140000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1140000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Prepaid Assets: 647000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 647000.00
TRMED.OL income_statement (annual, 2024-12-31) — Pretax Income: -42600000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Purchase Of PPE: -100000.00
TRMED.OL income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2400000.00
TRMED.OL income_statement (annual, 2024-12-31) — Research And Development: 3309000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Restricted Cash: 569000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 569000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Retained Earnings: -63060000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -63060000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
TRMED.OL income_statement (annual, 2024-12-31) — Selling General And Administration: 29071000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Share Issued: 281180892.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Share Issued: 281180892.00
TRMED.OL cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2800000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Stockholders Equity: 337144000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 337144000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Tangible Book Value: 54105000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 54105000.00
TRMED.OL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
TRMED.OL income_statement (annual, 2024-12-31) — Tax Provision: -400000.00
TRMED.OL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.01
TRMED.OL balance_sheet (annual, 2024-12-31) — Taxes Receivable: 1686000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 1686000.00
TRMED.OL cash_flow (annual, 2024-12-31) — Taxes Refund Paid: 0.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Total Assets: 414378000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Total Assets: 414378000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Total Capitalization: 337144000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 337144000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Total Debt: 737000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Total Debt: 737000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 337144000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 337144000.00
TRMED.OL income_statement (annual, 2024-12-31) — Total Expenses: 43900000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 77234000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 77234000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 284467000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 284467000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 54334000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 54334000.00
TRMED.OL income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -43900000.00
TRMED.OL income_statement (annual, 2024-12-31) — Total Other Finance Cost: -6000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Total Tax Payable: 1114000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 1114000.00
TRMED.OL balance_sheet (annual, 2024-12-31) — Working Capital: 107011000.00
TRMED.OL balance_sheet (quarterly, 2024-12-31) — Working Capital: 107011000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 21400000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 100000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 496500000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 8700000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 69800000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 224400000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 224400000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Common Stock: 69800000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 473500000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 28800000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Current Assets: 248400000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1100000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1100000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 28000000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 273600000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Gross PPE: 38900000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Inventory: 2600000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 473500000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 7600000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 7600000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Net PPE: 38900000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 199900000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 51900000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 348985920.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Other Current Assets: -100000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 4100000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Other Properties: 10100000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Other Receivables: 21400000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Payables: 22800000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -92800000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Share Issued: 348985920.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 473500000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 199900000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Total Assets: 561000000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 473500000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Total Debt: 8700000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 473500000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 87500000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 312500000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 59500000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 1400000.00
TRMED.OL balance_sheet (quarterly, 2025-06-30) — Working Capital: 220400000.00
TRMED.OL income_statement (annual, 2025-12-31) — +Operating Expense: 70100000.00
TRMED.OL income_statement (annual, 2025-12-31) — +Total Revenue: 400000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Accounts Payable: 14900000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 14900000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Accounts Receivable: 300000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 300000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 506200000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 506200000.00
TRMED.OL income_statement (annual, 2025-12-31) — Basic Average Shares: 332000000.00
TRMED.OL income_statement (annual, 2025-12-31) — Basic EPS: -0.17
TRMED.OL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 123400000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Capital Expenditure: -73100000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 171400000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 171400000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Capital Stock: 70800000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 70800000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 180600000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 180600000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 180600000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 180600000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Change In Inventory: -3000000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -500000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Change In Payable: -400000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Change In Receivables: -300000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Change In Working Capital: -4200000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Changes In Cash: 57200000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Common Stock: 70800000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Common Stock: 70800000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Common Stock Equity: 455900000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 455900000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Common Stock Issuance: 181500000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Construction In Progress: 67300000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 67300000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Current Assets: 199500000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Current Assets: 199500000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 12200000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 12200000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 12200000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 12200000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Current Liabilities: 43700000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 43700000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Depreciation: 20900000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 20900000.00
TRMED.OL income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 20900000.00
TRMED.OL income_statement (annual, 2025-12-31) — Depreciation Income Statement: 20900000.00
TRMED.OL income_statement (annual, 2025-12-31) — Diluted Average Shares: 332000000.00
TRMED.OL income_statement (annual, 2025-12-31) — Diluted EPS: -0.17
TRMED.OL income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -58000000.00
TRMED.OL income_statement (annual, 2025-12-31) — EBIT: -61700000.00
TRMED.OL income_statement (annual, 2025-12-31) — EBITDA: -40800000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 0.00
TRMED.OL cash_flow (annual, 2025-12-31) — End Cash Position: 180600000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Financing Cash Flow: 171200000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Free Cash Flow: -120600000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 264100000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 264100000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Gross PPE: 244200000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Gross PPE: 244200000.00
TRMED.OL income_statement (annual, 2025-12-31) — Interest Expense: 600000.00
TRMED.OL income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 600000.00
TRMED.OL income_statement (annual, 2025-12-31) — Interest Income: 6600000.00
TRMED.OL income_statement (annual, 2025-12-31) — Interest Income Non Operating: 6600000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Interest Paid Cff: -600000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Interest Received Cfi: 6600000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Inventory: 3000000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Inventory: 3000000.00
TRMED.OL balance_sheet (annual, 2025-12-31) — Invested Capital: 455900000.00
TRMED.OL balance_sheet (quarterly, 2025-12-31) — Invested Capital: 455900000.00
TRMED.OL cash_flow (annual, 2025-12-31) — Investing Cash Flow: -66500000.00